Phase 1/2 Study of HLD-0915 in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
Clinical Trial Grant
Awarded By
Halda Therapeutics, OpCo, Inc.
Start Date
September 26, 2025
End Date
September 7, 2030
Awarded By
Halda Therapeutics, OpCo, Inc.
Start Date
September 26, 2025
End Date
September 7, 2030